News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
On Tuesday, the Food and Drug Administration (FDA) modified its existing standards surrounding the COVID vaccine. Following ...
HHS Secretary Robert F. Kennedy Jr. announced that he has unilaterally struck the recommendation that healthy children and ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
Health Secretary Robert F. Kennedy Jr.’s decision to revoke the Covid vaccine recommendation for pregnant women has raised ...
This story has been updated to reflect changes to US Centers for Disease Control and Prevention immunization schedules. The US Department of Health and Human Services, under Secretary Robert F ...
New COVID-19 variant NB.1.8.1 is causing concern in California, where it was first detected by Stanford scientists. The FDA, ...
The CDC will no longer recommend the COVID-19 vaccine for pregnant women and healthy children. Updated COVID-19 shots will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback